These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9868032)

  • 21. [The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].
    Valdivia R M; Llanos C A; Zapata S C; Muñoz O N
    Rev Gastroenterol Peru; 2002; 22(4):279-86. PubMed ID: 12525843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CEA, AFP and CA 19-9 analysis in peritoneal fluid to differentiate causes of ascites formation.
    Kaleta EJ; Tolan NV; Ness KA; O'Kane D; Algeciras-Schimnich A
    Clin Biochem; 2013 Jun; 46(9):814-8. PubMed ID: 23454392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of effusion cytology in patients with simultaneous malignancy and ascites.
    Jha R; Shrestha HG; Sayami G; Pradhan SB
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):483-7. PubMed ID: 18603959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites.
    Nascimento I; Schaer R; Lemaire D; Freire S; Paule B; Carvalho S; Meyer R; Schaer-Barbosa H
    APMIS; 2004 Sep; 112(9):585-7. PubMed ID: 15601306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites.
    Kountouras J; Boura P; Tsapas G; Charisis K; Magoula I; Tsakiri I
    Anticancer Res; 1993; 13(6B):2441-5. PubMed ID: 8135481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
    Khandwalla HE; Fasakin Y; El-Serag HB
    Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of erythrocyte polyamines as a predictive method in tumour diagnosis. An animal study with chemically induced tumours.
    Quemener V; Havouis R; Khan NA; Martin C; Bouet F; Moulinoux JP
    Anticancer Res; 1995; 15(6B):2517-22. PubMed ID: 8669816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
    Schölmerich J; Volk BA; Köttgen E; Ehlers S; Gerok W
    Gastroenterology; 1984 Nov; 87(5):1160-4. PubMed ID: 6479538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The laparoscopic evaluation of ascites.
    Inadomi JM; Kapur S; Kinkhabwala M; Cello JP
    Gastrointest Endosc Clin N Am; 2001 Jan; 11(1):79-91. PubMed ID: 11175976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
    Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
    Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differentiation of malignant and non-malignant origin of ascites by determination of levels of cholesterol and lactate dehydrogenase in ascitic fluid is not absolute].
    Gasko R; Klímová N
    Vnitr Lek; 2000 Jan; 46(1):5-11. PubMed ID: 10953656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites.
    Abdel-Razik A; Eldars W; Elhelaly R; Elzehery R
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1868-1873. PubMed ID: 27010362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urine levels of polyamine in patients with or without cancer].
    Tsunoda A
    Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):816-25. PubMed ID: 3670267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic dilemma in an elderly woman with intractable ascites and elevated CA-125 level.
    Gupta S; Maheshwari A; Wuntkal R; Mazid T; Tongaonkar HB
    J Assoc Physicians India; 2006 Aug; 54():655-6. PubMed ID: 16941798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic possibilities of laparoscopy in the assessment of the stage in stomach cancer].
    Popova TN; Korzhenskiĭ FP
    Khirurgiia (Mosk); 1989 May; (5):33-4. PubMed ID: 2525649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinolytic characteristics and their significance in malignant, tuberculous and cirrhotic pleural and ascitic fluids.
    Lu XG; Mao JS; Tong JF; Zhu L; Liu J; Gong XB; Huang J
    Int J Lab Hematol; 2007 Apr; 29(2):132-8. PubMed ID: 17474886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection.
    Kiyici M; Nak SG; Budak F; Gurel S; Oral B; Dolar E; Gulten M
    J Gastroenterol Hepatol; 2006 Jun; 21(6):963-9. PubMed ID: 16724979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The analysis of ascitic fluid].
    González Maldonado JJ
    Rev Gastroenterol Mex; 1993; 58(2):170-2. PubMed ID: 7747028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-G is a potential tumor marker in malignant ascites.
    Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
    Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.